Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2016
∙
Karen Wong
Cholera vaccine update and proposed recommendations
2016
∙
Geeta Swamy, Kathryn Edwards, Karen Broder
Clinical Study of Tdap Safety in Pregnant Women
2016
∙
Marc Brisson
Comparing 2- and 3-dose 9-valent HPV Vaccine Schedules in the U.S.: A Cost-effectiveness Analysis
2016
∙
Alain Luxembourg
Comparison of immunogenicity of 2-dose and 3-dose regimens of 9-valent HPV vaccine
2016
∙
CoNaIn
CoNaIn Meeting Minutes on Dengue Vaccine
2016
∙
Lauri Markowitz
Considerations for Recommendations ACIP HPV Vaccines Work Group
2016
∙
Jessica MacNeil
Considerations for Use of MenACWY Vaccines In HIV-Infected Persons
2016
∙
Jessica MacNeil
Considerations for Use of MenACWY Vaccines In HIV-Infected Persons
2016
∙
Ismael Ortega-Sanchez
Cost-Effectiveness of Meningococcal Vaccination in HIV Infected People in the US
2016
∙
Tom Shimabukuro
End-of-Season Update: 2015-2016 Influenza Vaccine Safety Monitoring
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register